We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Valeant Pharmaceuticals International has established a drug pricing committee, a move that comes a week after company representatives pledged to review its pricing model in the face of withering congressional criticism.